Amnah Al-Sayyar

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Epithelial Mesenchymal Transition

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Shihab Kochumon, Amnah Al-Sayyar, Texy Jacob, Hossein Arefanian, Fatemah Bahman, Nourah Almansour, Fawaz Alzaid, Fahd Al-Mulla, Sardar Sindhu, Rasheed Ahmad
IL-1β-Induced CXCL10 Expression in THP-1 Monocytic Cells Involves the JNK/c-Jun and NF-κB-Mediated Signaling. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Shihab Kochumon, Amnah Al-Sayyar, Texy Jacob, Hossein Arefanian, Fatemah Bahman, Nourah Almansour, Fawaz Alzaid, Fahd Al-Mulla, Sardar Sindhu, Rasheed Ahmad
IL-1β-Induced CXCL10 Expression in THP-1 Monocytic Cells Involves the JNK/c-Jun and NF-κB-Mediated Signaling. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Shihab Kochumon, Amnah Al-Sayyar, Texy Jacob, Hossein Arefanian, Fatemah Bahman, Nourah Almansour, Fawaz Alzaid, Fahd Al-Mulla, Sardar Sindhu, Rasheed Ahmad
IL-1β-Induced CXCL10 Expression in THP-1 Monocytic Cells Involves the JNK/c-Jun and NF-κB-Mediated Signaling. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Amnah Al-Sayyar, Maha M Hammad, Michayla R Williams, Mohammed Al-Onaizi, Jehad Abubaker, Fawaz Alzaid
Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance. Metabolites 13 (3) (2023)
Amnah Al-Sayyar, Maha M Hammad, Michayla R Williams, Mohammed Al-Onaizi, Jehad Abubaker, Fawaz Alzaid
Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance. Metabolites 13 (3) (2023)
Amnah Al-Sayyar, Maha M Hammad, Michayla R Williams, Mohammed Al-Onaizi, Jehad Abubaker, Fawaz Alzaid
Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance. Metabolites 13 (3) (2023)
Shihab Kochumon, Hossein Arefanian, Sardar Sindhu, Reeby Thomas, Texy Jacob, Amnah Al-Sayyar, Steve Shenouda, Fatema Al-Rashed, Heikki A Koistinen, Fahd Al-Mulla, Jaakko Tuomilehto, Rasheed Ahmad
Expression of Steroid Receptor RNA Activator 1 (SRA1) in the Adipose Tissue Is Associated with TLRs and IRFs in Diabesity. Cells 11 (24) (2022)
Shihab Kochumon, Hossein Arefanian, Sardar Sindhu, Reeby Thomas, Texy Jacob, Amnah Al-Sayyar, Steve Shenouda, Fatema Al-Rashed, Heikki A Koistinen, Fahd Al-Mulla, Jaakko Tuomilehto, Rasheed Ahmad
Expression of Steroid Receptor RNA Activator 1 (SRA1) in the Adipose Tissue Is Associated with TLRs and IRFs in Diabesity. Cells 11 (24) (2022)
Shihab Kochumon, Hossein Arefanian, Sardar Sindhu, Reeby Thomas, Texy Jacob, Amnah Al-Sayyar, Steve Shenouda, Fatema Al-Rashed, Heikki A Koistinen, Fahd Al-Mulla, Jaakko Tuomilehto, Rasheed Ahmad
Expression of Steroid Receptor RNA Activator 1 (SRA1) in the Adipose Tissue Is Associated with TLRs and IRFs in Diabesity. Cells 11 (24) (2022)
Shihab Kochumon, Hossein Arefanian, Sardar Sindhu, Reeby Thomas, Texy Jacob, Amnah Al-Sayyar, Steve Shenouda, Fatema Al-Rashed, Heikki A Koistinen, Fahd Al-Mulla, Jaakko Tuomilehto, Rasheed Ahmad
Expression of Steroid Receptor RNA Activator 1 (SRA1) in the Adipose Tissue Is Associated with TLRs and IRFs in Diabesity. Cells 11 (24) (2022)
Shihab Kochumon, Amal Hasan, Fatema Al-Rashed, Sardar Sindhu, Reeby Thomas, Texy Jacob, Amnah Al-Sayyar, Hossein Arefanian, Ashraf Al Madhoun, Ebaa Al-Ozairi, Fawaz Alzaid, Heikki A Koistinen, Fahd Al-Mulla, Jaakko Tuomilehto, Rasheed Ahmad
Increased Adipose Tissue Expression of IL-23 Associates with Inflammatory Markers in People with High LDL Cholesterol. Cells 11 (19) (2022)
Shihab Kochumon, Hossein Arefanian, Sardar Sindhu, Reeby Thomas, Texy Jacob, Amnah Al-Sayyar, Steve Shenouda, Fatema Al-Rashed, Heikki A Koistinen, Fahd Al-Mulla, Jaakko Tuomilehto, Rasheed Ahmad
Expression of Steroid Receptor RNA Activator 1 (SRA1) in the Adipose Tissue Is Associated with TLRs and IRFs in Diabesity. Cells 11 (24) (2022)
Shihab Kochumon, Amnah Al-Sayyar, Texy Jacob, Amal Hasan, Fahd Al-Mulla, Sardar Sindhu, Rasheed Ahmad
TNF-α Increases IP-10 Expression in MCF-7 Breast Cancer Cells via Activation of the JNK/c-Jun Pathways. Biomolecules 11 (9) (2021)